Article Details

AstraZeneca to Buy China's Gracell Bio for up to $1.2 Billion - The Economic Times

Retrieved on: 2023-12-26 18:25:37

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to Buy China's Gracell Bio for up to $1.2 Billion - The Economic Times. View article details on hiswai:

Excerpt

The cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per ADS of ...

Article found on: economictimes.indiatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up